 | • レポートコード：QYR9N8021 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、セロトニン症候群のグローバル市場について調査・分析したレポートで、種類別（セロトニン拮抗薬、支持療法、消化管除染、その他）、用途別（病院での使用、診療所での使用、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・セロトニン症候群の世界市場規模 ・主要企業別市場シェア ・セロトニン症候群の世界市場規模：種類別（セロトニン拮抗薬、支持療法、消化管除染、その他） ・セロトニン症候群の世界市場規模：用途別（病院での使用、診療所での使用、その他） ・セロトニン症候群のアメリカ市場規模（種類別、用途別） ・セロトニン症候群のヨーロッパ市場規模（種類別、用途別） ・セロトニン症候群の中国市場規模（種類別、用途別） ・セロトニン症候群の日本市場規模（種類別、用途別） ・セロトニン症候群の東南アジア市場規模（種類別、用途別） ・セロトニン症候群のインド市場規模（種類別、用途別） ・セロトニン症候群の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・セロトニン症候群の世界市場予測（2019年-2025年） ・セロトニン症候群の地域別市場予測（2019年-2025年） ... |
Serotonin syndrome is a group of symptoms such as high body temperature, agitation, increased reflexes, tremor, sweating, dilated pupils, diarrhoea etc. due to use of serotonergic drugs. Serious complications such as seizures and extensive muscle breakdown may occur which may lead to death.US accounts for the maximum market share due to greater use of medications and greater expenditure on healthcare. The faster market uptake of new technology and devices in the US is also an important driver of the market for global serotonin syndrome diagnosis and treatment. Europe is the second largest market due to large disposable income and rising awareness. Asia Pacific region is expected to have the most future potential and it is estimated to be led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The regions of Africa are expected to witness a moderate growth due to poor economic and political conditions and poor healthcare penetration.
In 2018, the global Serotonin Syndrome market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Serotonin Syndrome status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Serotonin Syndrome development in United States, Europe and China.
The key players covered in this study
AstraZeneca Plc.
Eli Lilly and Company
Forest Laboratories Inc.
GlaxoSmithKline plc.
Johnson & Johnson
Merck & Co., Inc.
Pfizer, Inc.
Sanofi S.A.
Ciron Drugs & Pharmaceuticals Pvt. Ltd.
Market segment by Type, the product can be split into
Serotonin Antagonists
Supportive Care
Gastrointestinal Decontamination
Others
Market segment by Application, split into
Hospital Use
Clinic Use
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Serotonin Syndrome status, future forecast, growth opportunity, key market and key players.
To present the Serotonin Syndrome development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Serotonin Syndrome are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Serotonin Syndrome Market Size Growth Rate by Type (2014-2025)
1.4.2 Serotonin Antagonists
1.4.3 Supportive Care
1.4.4 Gastrointestinal Decontamination
1.4.5 Others
1.5 Market by Application
1.5.1 Global Serotonin Syndrome Market Share by Application (2014-2025)
1.5.2 Hospital Use
1.5.3 Clinic Use
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Serotonin Syndrome Market Size
2.2 Serotonin Syndrome Growth Trends by Regions
2.2.1 Serotonin Syndrome Market Size by Regions (2014-2025)
2.2.2 Serotonin Syndrome Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Serotonin Syndrome Market Size by Manufacturers
3.1.1 Global Serotonin Syndrome Revenue by Manufacturers (2014-2019)
3.1.2 Global Serotonin Syndrome Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Serotonin Syndrome Market Concentration Ratio (CR5 and HHI)
3.2 Serotonin Syndrome Key Players Head office and Area Served
3.3 Key Players Serotonin Syndrome Product/Solution/Service
3.4 Date of Enter into Serotonin Syndrome Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Serotonin Syndrome Market Size by Type (2014-2019)
4.2 Global Serotonin Syndrome Market Size by Application (2014-2019)
5 United States
5.1 United States Serotonin Syndrome Market Size (2014-2019)
5.2 Serotonin Syndrome Key Players in United States
5.3 United States Serotonin Syndrome Market Size by Type
5.4 United States Serotonin Syndrome Market Size by Application
6 Europe
6.1 Europe Serotonin Syndrome Market Size (2014-2019)
6.2 Serotonin Syndrome Key Players in Europe
6.3 Europe Serotonin Syndrome Market Size by Type
6.4 Europe Serotonin Syndrome Market Size by Application
7 China
7.1 China Serotonin Syndrome Market Size (2014-2019)
7.2 Serotonin Syndrome Key Players in China
7.3 China Serotonin Syndrome Market Size by Type
7.4 China Serotonin Syndrome Market Size by Application
8 Japan
8.1 Japan Serotonin Syndrome Market Size (2014-2019)
8.2 Serotonin Syndrome Key Players in Japan
8.3 Japan Serotonin Syndrome Market Size by Type
8.4 Japan Serotonin Syndrome Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Serotonin Syndrome Market Size (2014-2019)
9.2 Serotonin Syndrome Key Players in Southeast Asia
9.3 Southeast Asia Serotonin Syndrome Market Size by Type
9.4 Southeast Asia Serotonin Syndrome Market Size by Application
10 India
10.1 India Serotonin Syndrome Market Size (2014-2019)
10.2 Serotonin Syndrome Key Players in India
10.3 India Serotonin Syndrome Market Size by Type
10.4 India Serotonin Syndrome Market Size by Application
11 Central & South America
11.1 Central & South America Serotonin Syndrome Market Size (2014-2019)
11.2 Serotonin Syndrome Key Players in Central & South America
11.3 Central & South America Serotonin Syndrome Market Size by Type
11.4 Central & South America Serotonin Syndrome Market Size by Application
12 International Players Profiles
12.1 AstraZeneca Plc.
12.1.1 AstraZeneca Plc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Serotonin Syndrome Introduction
12.1.4 AstraZeneca Plc. Revenue in Serotonin Syndrome Business (2014-2019)
12.1.5 AstraZeneca Plc. Recent Development
12.2 Eli Lilly and Company
12.2.1 Eli Lilly and Company Company Details
12.2.2 Company Description and Business Overview
12.2.3 Serotonin Syndrome Introduction
12.2.4 Eli Lilly and Company Revenue in Serotonin Syndrome Business (2014-2019)
12.2.5 Eli Lilly and Company Recent Development
12.3 Forest Laboratories Inc.
12.3.1 Forest Laboratories Inc. Company Details
12.3.2 Company Description and Business Overview
12.3.3 Serotonin Syndrome Introduction
12.3.4 Forest Laboratories Inc. Revenue in Serotonin Syndrome Business (2014-2019)
12.3.5 Forest Laboratories Inc. Recent Development
12.4 GlaxoSmithKline plc.
12.4.1 GlaxoSmithKline plc. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Serotonin Syndrome Introduction
12.4.4 GlaxoSmithKline plc. Revenue in Serotonin Syndrome Business (2014-2019)
12.4.5 GlaxoSmithKline plc. Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Company Details
12.5.2 Company Description and Business Overview
12.5.3 Serotonin Syndrome Introduction
12.5.4 Johnson & Johnson Revenue in Serotonin Syndrome Business (2014-2019)
12.5.5 Johnson & Johnson Recent Development
12.6 Merck & Co., Inc.
12.6.1 Merck & Co., Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Serotonin Syndrome Introduction
12.6.4 Merck & Co., Inc. Revenue in Serotonin Syndrome Business (2014-2019)
12.6.5 Merck & Co., Inc. Recent Development
12.7 Pfizer, Inc.
12.7.1 Pfizer, Inc. Company Details
12.7.2 Company Description and Business Overview
12.7.3 Serotonin Syndrome Introduction
12.7.4 Pfizer, Inc. Revenue in Serotonin Syndrome Business (2014-2019)
12.7.5 Pfizer, Inc. Recent Development
12.8 Sanofi S.A.
12.8.1 Sanofi S.A. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Serotonin Syndrome Introduction
12.8.4 Sanofi S.A. Revenue in Serotonin Syndrome Business (2014-2019)
12.8.5 Sanofi S.A. Recent Development
12.9 Ciron Drugs & Pharmaceuticals Pvt. Ltd.
12.9.1 Ciron Drugs & Pharmaceuticals Pvt. Ltd. Company Details
12.9.2 Company Description and Business Overview
12.9.3 Serotonin Syndrome Introduction
12.9.4 Ciron Drugs & Pharmaceuticals Pvt. Ltd. Revenue in Serotonin Syndrome Business (2014-2019)
12.9.5 Ciron Drugs & Pharmaceuticals Pvt. Ltd. Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Serotonin Syndrome Key Market Segments
Table Key Players Serotonin Syndrome Covered
Table Global Serotonin Syndrome Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Serotonin Syndrome Market Size Market Share by Type 2014-2025
Figure Serotonin Antagonists Figures
Table Key Players of Serotonin Antagonists
Figure Supportive Care Figures
Table Key Players of Supportive Care
Figure Gastrointestinal Decontamination Figures
Table Key Players of Gastrointestinal Decontamination
Figure Others Figures
Table Key Players of Others
Table Global Serotonin Syndrome Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Use Case Studies
Figure Clinic Use Case Studies
Figure Other Case Studies
Figure Serotonin Syndrome Report Years Considered
Table Global Serotonin Syndrome Market Size 2014-2025 (Million US$)
Figure Global Serotonin Syndrome Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Serotonin Syndrome Market Size by Regions 2014-2025 (Million US$)
Table Global Serotonin Syndrome Market Size by Regions 2014-2019 (Million US$)
Table Global Serotonin Syndrome Market Share by Regions 2014-2019
Figure Global Serotonin Syndrome Market Share by Regions 2014-2019
Figure Global Serotonin Syndrome Market Share by Regions 2019
Table Market Top Trends
Table Global Serotonin Syndrome Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Serotonin Syndrome Market Share by Manufacturers (2014-2019)
Figure Global Serotonin Syndrome Market Share by Manufacturers in 2018
Table Global Serotonin Syndrome Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Serotonin Syndrome Product/Solution/Service
Table Date of Enter into Serotonin Syndrome Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Serotonin Syndrome Market Size by Type (2014-2019) (Million US$)
Table Global Serotonin Syndrome Market Size Share by Type (2014-2019)
Figure Global Serotonin Syndrome Market Size Market Share by Type (2014-2019)
Table Global Serotonin Syndrome Market Size by Application (2014-2019) (Million US$)
Table Global Serotonin Syndrome Market Size Share by Application (2014-2019)
Figure Global Serotonin Syndrome Market Size Market Share by Application (2014-2019)
Figure Global Serotonin Syndrome Revenue Market Share by Application in 2018
Figure United States Serotonin Syndrome Market Size 2014-2019 (Million US$)
Table United States Key Players Serotonin Syndrome Revenue (2018-2019) (Million US$)
Table United States Key Players Serotonin Syndrome Market Share (2018-2019)
Table United States Serotonin Syndrome Market Size by Type (2014-2019) (Million US$)
Table United States Serotonin Syndrome Market Share by Type (2014-2019)
Table United States Serotonin Syndrome Market Size by Application (2014-2019) (Million US$)
Table United States Serotonin Syndrome Market Share by Application (2014-2019)
Figure Europe Serotonin Syndrome Market Size 2014-2019 (Million US$)
Table Europe Key Players Serotonin Syndrome Revenue (2018-2019) (Million US$)
Table Europe Key Players Serotonin Syndrome Market Share (2018-2019)
Table Europe Serotonin Syndrome Market Size by Type (2014-2019) (Million US$)
Table Europe Serotonin Syndrome Market Share by Type (2014-2019)
Table Europe Serotonin Syndrome Market Size by Application (2014-2019) (Million US$)
Table Europe Serotonin Syndrome Market Share by Application (2014-2019)
Figure China Serotonin Syndrome Market Size 2014-2019 (Million US$)
Table China Key Players Serotonin Syndrome Revenue (2018-2019) (Million US$)
Table China Key Players Serotonin Syndrome Market Share (2018-2019)
Table China Serotonin Syndrome Market Size by Type (2014-20189) (Million US$)
Table China Serotonin Syndrome Market Share by Type (2014-2019)
Table China Serotonin Syndrome Market Size by Application (2014-2019) (Million US$)
Table China Serotonin Syndrome Market Share by Application (2014-2019)
Figure Japan Serotonin Syndrome Market Size 2014-2019 (Million US$)
Table Japan Key Players Serotonin Syndrome Revenue (2018-2019) (Million US$)
Table Japan Key Players Serotonin Syndrome Market Share (2018-2019)
Table Japan Serotonin Syndrome Market Size by Type (2014-2019) (Million US$)
Table Japan Serotonin Syndrome Market Share by Type (2014-2019)
Table Japan Serotonin Syndrome Market Size by Application (2014-2019) (Million US$)
Table Japan Serotonin Syndrome Market Share by Application (2014-2019)
Figure Southeast Asia Serotonin Syndrome Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Serotonin Syndrome Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Serotonin Syndrome Market Share (2018-2019)
Table Southeast Asia Serotonin Syndrome Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Serotonin Syndrome Market Share by Type (2014-2019)
Table Southeast Asia Serotonin Syndrome Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Serotonin Syndrome Market Share by Application (2014-2019)
Figure India Serotonin Syndrome Market Size 2014-2019 (Million US$)
Table India Key Players Serotonin Syndrome Revenue (2018-2019) (Million US$)
Table India Key Players Serotonin Syndrome Market Share (2018-2019)
Table India Serotonin Syndrome Market Size by Type (2014-2019) (Million US$)
Table India Serotonin Syndrome Market Share by Type (2014-2019)
Table India Serotonin Syndrome Market Size by Application (2014-2019) (Million US$)
Table India Serotonin Syndrome Market Share by Application (2014-2019)
Figure Central & South America Serotonin Syndrome Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Serotonin Syndrome Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Serotonin Syndrome Market Share (2018-2019)
Table Central & South America Serotonin Syndrome Market Size by Type (2014-2019) (Million US$)
Table Central & South America Serotonin Syndrome Market Share by Type (2014-2019)
Table Central & South America Serotonin Syndrome Market Size by Application (2014-2019) (Million US$)
Table Central & South America Serotonin Syndrome Market Share by Application (2014-2019)
Table AstraZeneca Plc. Company Details
Table AstraZeneca Plc. Revenue in Serotonin Syndrome Business (2014-2019) (Million US$)
Figure AstraZeneca Plc. Revenue Growth Rate in Serotonin Syndrome Business (2014-2019)
Table AstraZeneca Plc. Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Revenue in Serotonin Syndrome Business (2014-2019)(Million US$)
Figure Eli Lilly and Company Revenue Growth Rate in Serotonin Syndrome Business (2014-2019)
Table Eli Lilly and Company Recent Development
Table Forest Laboratories Inc. Company Details
Table Forest Laboratories Inc. Revenue in Serotonin Syndrome Business (2014-2019)(Million US$)
Figure Forest Laboratories Inc. Revenue Growth Rate in Serotonin Syndrome Business (2014-2019)
Table Forest Laboratories Inc. Recent Development
Table GlaxoSmithKline plc. Company Details
Table GlaxoSmithKline plc. Revenue in Serotonin Syndrome Business (2014-2019)(Million US$)
Figure GlaxoSmithKline plc. Revenue Growth Rate in Serotonin Syndrome Business (2014-2019)
Table GlaxoSmithKline plc. Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Serotonin Syndrome Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Serotonin Syndrome Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Merck & Co., Inc. Company Details
Table Merck & Co., Inc. Revenue in Serotonin Syndrome Business (2014-2019)(Million US$)
Figure Merck & Co., Inc. Revenue Growth Rate in Serotonin Syndrome Business (2014-2019)
Table Merck & Co., Inc. Recent Development
Table Pfizer, Inc. Company Details
Table Pfizer, Inc. Revenue in Serotonin Syndrome Business (2014-2019)(Million US$)
Figure Pfizer, Inc. Revenue Growth Rate in Serotonin Syndrome Business (2014-2019)
Table Pfizer, Inc. Recent Development
Table Sanofi S.A. Company Details
Table Sanofi S.A. Revenue in Serotonin Syndrome Business (2014-2019)(Million US$)
Figure Sanofi S.A. Revenue Growth Rate in Serotonin Syndrome Business (2014-2019)
Table Sanofi S.A. Recent Development
Table Ciron Drugs & Pharmaceuticals Pvt. Ltd. Company Details
Table Ciron Drugs & Pharmaceuticals Pvt. Ltd. Revenue in Serotonin Syndrome Business (2014-2019)(Million US$)
Figure Ciron Drugs & Pharmaceuticals Pvt. Ltd. Revenue Growth Rate in Serotonin Syndrome Business (2014-2019)
Table Ciron Drugs & Pharmaceuticals Pvt. Ltd. Recent Development
Table Global Serotonin Syndrome Market Size by Regions (Million US$) 2019-2025
Figure Global Serotonin Syndrome Market Size Share by Regions (2019-2025)
Figure Global Serotonin Syndrome Market Size Share by Regions in 2025
Figure United States Serotonin Syndrome Market Size Forecast (2019-2025)(Million USD)
Figure Europe Serotonin Syndrome Market Size Forecast (2019-2025)(Million USD)
Figure China Serotonin Syndrome Market Size Forecast (2019-2025)(Million USD)
Figure Japan Serotonin Syndrome Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Serotonin Syndrome Market Size Forecast (2019-2025)(Million USD)
Figure India Serotonin Syndrome Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Serotonin Syndrome Market Size Forecast (2019-2025)(Million USD)
Table Global Serotonin Syndrome Market Size by Product (2019-2025) (Million US$)
Figure Global Serotonin Syndrome Market Size by Product (2019-2025)
Figure Global Serotonin Syndrome Market Size by Product in 2025
Table Global Serotonin Syndrome Market Size by Application (2019-2025) (Million US$)
Figure Global Serotonin Syndrome Market Size by Application (2019-2025)
Figure Global Serotonin Syndrome Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界のセロトニン症候群の治療市場：市場規模・現状・予測 Serotonin syndrome refers to a group of symptoms and signs caused by the hyperfunction of serotonin in the nervous system, which is manifested as the triad of cognitive function/behavior change, neuromuscular abnormality and autonomic nervous instability.In 2018, the global Serotonin Syndrome Treatm…- 世界のセロトニンサプリメント市場2019 The global Serotonin Suppliment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Serotonin Suppliment market status and forecast, categorizes the global Serotonin Suppliment market size (valu…
- 世界の骨髄異形成症候群（MDS）薬市場：市場規模・現状・予測 Myelodysplastic syndrome is caused by mutation of one or more genes that control development of blood cells. It is one of the most common malignant hematological diseases that affects five out of every 100,000 people in U.S. annually. An estimated 60,000 people in U.S. live with MDS, and approximate…
- 世界の周期性発熱症候群市場：市場規模・現状・予測 Periodic fever syndrome are a set of disorders characterized by recurrent episodes of systemic and organ-specific inflammation.The syndromes are diverse, but tend to cause episodes of fever, joint pains, skin rashes, abdominal pains and may lead to chronic complications such as amyloidosis. In 2018,…
- 世界のパリーロンバーグ症候群市場：市場規模・現状・予測 Parry–Romberg syndrome, also known as progressive hemifacial atrophy, is a rare disease characterized by progressive shrinkage and degeneration of the tissues beneath the skin, usually on only one side of the face (hemifacial atrophy) but occasionally extending to other parts of the body. An autoimm…